Apollomics, Inc.

US$19.00As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:APLMHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (55.10%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 1.56
PE TTM —
TSR TTM 36.01%
Mkt cap US$41.72M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$20
3.51%
(23.65%)
Hold 11|2|1|2|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.27
0.26
0.28
0.29
21.12%
8.44%
9.60%
11.59%
Revenue$M
3.127
3.226
3.370
3.426
4.59%
3.96%
9.59%
7.91%
Peers (US$41.72M)
Cap (US$)
PE
41.60M
—
40.84M
—
Capital
TTM
5Y
10Y
Leveragex
1.650
0.350
0.318
EBIT/Intx
0.977
0.293
0.249
Own earn%
22.92
91.30
78.72
Sh yield%
18.04
7.63
15.14
Owners
Insiders/Inst%
1.70
29.33
Short interest%
2.61
SBC / revenue%
2.73
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
19–27
$1 testx
—
Incr. ROIC%
7